UnitedHealth Group Stock Rises 14.2% Amid Strong Earnings and Raised Guidance

UnitedHealth Group stock has seen a notable recovery in 2026. As of September 18, it was trading at $377.06 on the New York Stock Exchange, up 14.2% from its level at the beginning of the year.

The stock's performance is attributed to the company's recent earnings delivery and updated outlook. In Q2 2026, UnitedHealth Group beat expectations on both revenue and earnings per share and raised its full-year guidance, keeping its medical loss ratio at 86.7%.

Analysts have increased their earnings estimates for UnitedHealth Group for the coming quarters, with no downgrades, supporting the view that the company's operational trends are improving alongside its financial performance.